Alternative Allogeneic Donor Sources for Transplantation for Childhood Diseases: Unrelated Cord Blood and Haploidentical Family Donors

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 1 SUPPL., 2008, Pages 44-53

  Cairo, Mitchell S ^a   Rocha, Vanderson ^b   Gluckman, Eliane ^b   Hale, Gregory ^c   Wagner, John ^d  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b SAINT LOUIS HOSPITAL   (France)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Alternative allogeneic donors; Haploidentical transplants; Pediatric; Unrelated donor transplants

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CALCINEURIN INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; FLUDARABINE; INTERLEUKIN 2; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RITUXIMAB; STEROID; THYMOCYTE ANTIBODY;

ACUTE LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CHILDHOOD DISEASE; COMBINATION CHEMOTHERAPY; CORD BLOOD STEM CELL TRANSPLANTATION; ENGRAFTMENT; FAMILY; FANCONI ANEMIA; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINOPATHY; HLA MATCHING; HUMAN; HURLER SYNDROME; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LIVING DONOR; METABOLIC DISORDER; MONOTHERAPY; OUTCOME ASSESSMENT; SICKLE CELL ANEMIA; T CELL DEPLETION; THALASSEMIA; UMBILICAL CORD BLOOD; UNSPECIFIED SIDE EFFECT; WHOLE BODY RADIATION;

CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; TISSUE DONORS;

EID: 37349042204     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.10.007     Document Type: Article

References (71)

1. Thomas E.D., Lochte Jr. H.L., Lu W.C., and Ferrebee J.W. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 257 (1957) 491-496
2. Wagner J.E., Kernan N.A., Steinbuch M., Broxmeyer H.E., and Gluckman E. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 346 (1995) 214-219
3. Kurtzberg J., Laughlin M., Graham M.L., et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 335 (1996) 157-166
4. Wagner J.E., Rosenthal J., Sweetman R., et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 88 (1996) 795-802
5. Brunstein C.G., Setubal D.C., and Wagner J.E. Expanding the role of umbilical cord blood transplantation. Br J Haematol 137 (2007) 20-35
6. Cairo M.S., and Wagner J.E. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 90 (1997) 4665-4678
7. Barker J.N., Krepski T.P., DeFor T.E., Davies S.M., Wagner J.E., and Weisdorf D.J. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 8 (2002) 257-260
8. Dalle J.H., Duval M., Moghrabi A., et al. Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant 33 (2004) 605-611
9. Davey S., Armitage S., Rocha V., et al. The London Cord Blood Bank: analysis of banking and transplantation outcome. Br J Haematol 125 (2004) 358-365
10. Gluckman E., Rocha V., Boyer-Chammard A., et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 337 (1997) 373-381
11. Rubinstein P., Carrier C., Scaradavou A., et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339 (1998) 1565-1577
12. Styczynski J., Cheung Y.K., Garvin J., et al. Outcomes of unrelated cord blood transplantation in pediatric recipients. Bone Marrow Transplant 34 (2004) 129-136
13. Wagner J.E., Barker J.N., DeFor T.E., et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100 (2002) 1611-1618
14. Eapen M., Rubinstein P., Zhang M.J., et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 369 (2007) 1947-1954
15. Grewal S.S., Barker J.N., Davies S.M., and Wagner J.E. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?. Blood 101 (2003) 4233-4244
16. Rocha V., Cornish J., Sievers E.L., et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 97 (2001) 2962-2971
17. Barker J.N., Hough R.E., van Burik J.A., et al. Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. Biol Blood Marrow Transplant 11 (2005) 362-370
18. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105 (2005) 1343-1347
19. Bradley M.B., Satwani P., Baldinger L., et al. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases. Bone Marrow Transplant 40 (2007) 621-631
20. Shpall E.J., Quinones R., Giller R., et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 8 (2002) 368-376
21. Chang C.C., Satwani P., Oberfield N., Vlad G., Simpson L.L., and Cairo M.S. Increased induction of allogeneic-specific cord blood CD4+CD25+ regulatory T (Treg) cells: a comparative study of naive and antigenic-specific cord blood Treg cells. Exp Hematol 33 (2005) 1508-1520
22. Ayello J., van de Ven C., Fortino W., et al. Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering. Biol Blood Marrow Transplant 12 (2006) 608-622
23. van de Ven C, Collins D, Bradley MB, Morris E, Cairo MS. The potential of umbilical cord blood multipotent stem cells for non-hematopoietic tissue and cell regeneration. Exp Hematol. (in press).
24. Gluckman E., Broxmeyer H.A., Auerbach A.D., et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321 (1989) 1174-1178
25. Gluckman E., Rocha V., Arcese W., et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 32 (2004) 397-407
26. Michel G., Rocha V., Chevret S., et al. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood 102 (2003) 4290-4297
27. Gluckman E, Rocha V, Ionescu I, Eurocord eaobo. Fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant. (in press).
28. Escolar M.L., Poe M.D., Provenzale J.M., et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med 352 (2005) 2069-2081
29. Staba S.L., Escolar M.L., Poe M., et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 350 (2004) 1960-1969
30. Boelens J.J., Rocha V., Aldenhoven M., et al. Risk factor analysis of outcomes after unrelated cord blood transplantation for children with Hurler's Syndrom An Eurocord-Duke University collaborative study. Blood (2007) (ASH abstract submitted)
31. Locatelli F., Rocha V., Reed W., et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 101 (2003) 2137-2143
32. Hwang W.Y., Samuel M., Tan D., Koh L.P., Lim W., and Linn Y.C. A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients. Biol Blood Marrow Transplant 13 (2007) 444-453
33. Curtis R.E., Travis L.B., Rowlings P.A., et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 94 (1999) 2208-2216
34. Henslee-Downey P.J. Allogeneic transplantation across major HLA barriers. Best Pract Res 14 (2001) 741-754
35. Szydlo R., Goldman J.M., Klein J.P., et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 15 (1997) 1767-1777
36. Leung W., Iyengar R., Turner V., et al. Determinants of antileukemia effects of allogeneic NK cells. J Immunol 172 (2004) 644-650
37. Lang P., Handgretinger R., Niethammer D., et al. Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia. Blood 101 (2003) 1630-1636
38. Handgretinger R., Klingebiel T., Lang P., Gordon P., and Niethammer D. Megadose transplantation of highly purified haploidentical stem cells: current results and future prospects. Pediatr Transplant 7 Suppl 3 (2003) 51-55
39. Aversa F., Tabilio A., Velardi A., et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 339 (1998) 1186-1193
40. Aversa F., Terenzi A., Tabilio A., et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 23 (2005) 3447-3454
41. Marks D.I., Khattry N., Cummins M., et al. Haploidentical stem cell transplantation for children with acute leukaemia. Br J Haematol 134 (2006) 196-201
42. Gordon P.R., Leimig T., Mueller I., et al. A large-scale method for T cell depletion: towards graft engineering of mobilized peripheral blood stem cells. Bone Marrow Transplant 30 (2002) 69-74
43. Hale G.A., Kasow K., Gan K., et al. Haploidentical stem cell transplantation with CD3 depleted moblized peripheral blood stem cell grafts for children with hematologic malignancies. Blood 106 (2005) 2910a
44. Hale G.A., Kasow K., Madden R., et al. Mismatched family member donor transplantation for patients with refractory hematologic malignancies: long-term follow-up of a prospective clinical trial. Blood 810 (2006) 895a
45. Huang X.J., Liu D.H., Liu K.Y., et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant 38 (2006) 291-297
46. Lu D.P., Dong L., Wu T., et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 107 (2006) 3065-3073
47. Guinan E.C., Boussiotis V.A., Neuberg D., et al. Transplantation of anergic histoincompatible bone marrow allografts. N Engl J Med 340 (1999) 1704-1714
48. Rizzieri D.A., Koh L.P., Long G.D., et al. Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution. J Clin Oncol 25 (2007) 690-697
49. Klingebiel T., Handgretinger R., Lang P., Bader P., and Niethammer D. Haploidentical transplantation for acute lymphoblastic leukemia in childhood. Blood Rev 18 (2004) 181-192
50. Bader P., Kreyenberg H., Hoelle W., et al. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?. J Clin Oncol 22 (2004) 1696-1705
51. Bader P., Kreyenberg H., Hoelle W., et al. Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective. Bone Marrow Transplant 33 (2004) 815-821
52. Chen X., Hale G.A., Barfield R., et al. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. Br J Haematol 135 (2006) 524-532
53. Amrolia P.J., Muccioli-Casadei G., Huls H., et al. Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation. Blood 108 (2006) 1797-1808
54. Chen X., Hale G.A., Neale G.A., et al. A novel approach for the analysis of T-cell reconstitution by using a T-cell receptor beta-based oligonucleotide microarray in hematopoietic stem cell transplantation. Exp Hematol 35 (2007) 831-841
55. Howden B.P., Michaelides A., Spelman D.W., et al. Cytomegalovirus viral load monitoring after allogeneic bone marrow transplantation in patients receiving antiviral prophylaxis. Bone Marrow Transplant 32 (2003) 795-800
56. Kuehnle I., Huls M.H., Liu Z., et al. CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. Blood 95 (2000) 1502-1505
57. Yusuf U., Hale G.A., Carr J., et al. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation 81 (2006) 1398-1404
58. Larocca A., Piaggio G., Podesta M., et al. Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation. Haematologica 91 (2006) 935-940
59. Lewalle P., Triffet A., Delforge A., et al. Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study. Bone Marrow Transplant 31 (2003) 39-44
60. Leung W., Iyengar R., Triplett B., et al. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J Immunol 174 (2005) 6540-6545
61. Passweg J.R., Stern M., Koehl U., Uharek L., and Tichelli A. Use of natural killer cells in hematopoetic stem cell transplantation. Bone Marrow Transplant 35 (2005) 637-643
62. Miller J.S., Soignier Y., Panoskaltsis-Mortari A., et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 105 (2005) 3051-3057
63. Leung W., Iyengar R., Leimig T., Holladay M.S., Houston J., and Handgretinger R. Phenotype and function of human natural killer cells purified by using a clinical-scale immunomagnetic method. Cancer Immunol Immunother 54 (2005) 389-394
64. Burlingham W.J., Grailer A.P., Heisey D.M., et al. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med 339 (1998) 1657-1664
65. Umeda K., Adachi S., Ishihara H., et al. Successful T-cell-replete peripheral blood stem cell transplantation from HLA-haploidentical microchimeric mother to daughter with refractory acute lymphoblastic leukemia using reduced-intensity conditioning. Bone Marrow Transplant 31 (2003) 1061-1063
66. Ichinohe T., Teshima T., Matsuoka K., Maruya E., and Saji H. Fetal-maternal microchimerism: impact on hematopoietic stem cell transplantation. Curr Opin Immunol 17 (2005) 546-552
67. Obama K., Utsunomiya A., Takatsuka Y., and Takemoto Y. Reduced-intensity non-T-cell depleted HLA-haploidentical stem cell transplantation for older patients based on the concept of feto-maternal tolerance. Bone Marrow Transplant 34 (2004) 897-899
68. Narimatsu H., Morishita Y., Saito S., et al. Conditioning regimen of melphalan, fludarabine and total body irradiation in unmanipulated HLA haploidentical stem cell transplantation based on feto-maternal tolerance. Intern Med 43 (2004) 1063-1067
69. Yoshihara T., Morimoto A., Inukai T., et al. Non-T-cell-depleted HLA haploidentical stem cell transplantation based on feto-maternal microchimerism in pediatric patients with advanced malignancies. Bone Marrow Transplant 34 (2004) 373-375
70. Shimazaki C., Ochiai N., Uchida R., et al. Non-T-cell-depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism 54. Blood 101 (2003) 3334-3336
71. van Rood J.J., Loberiza Jr. F.R., Zhang M.J., et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood 99 (2002) 1572-1577